Home/Filings/4/0001048477-24-000036
4//SEC Filing

Ajer Jeffrey Robert 4

Accession 0001048477-24-000036

CIK 0001048477other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 8:36 PM ET

Size

4.5 KB

Accession

0001048477-24-000036

Insider Transaction Report

Form 4
Period: 2024-03-15
Ajer Jeffrey Robert
SVP, Chief Commercial Of
Transactions
  • Tax Payment

    Common Stock

    2024-03-15$83.87/sh22,580$1,893,78571,467 total

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0001557533

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 8:36 PM ET
Size
4.5 KB